France · Delayed Price · Currency is EUR Ipsos Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 revenue declined 2.4% year-over-year due to currency headwinds, but order book growth and strong momentum in China and public affairs support confidence in achieving 2%-3% organic growth for the full year. Profitability is expected to remain stable despite regional and acquisition impacts.
-
A new strategy targets AI-driven transformation, rapid innovation, and global managed services to accelerate growth and profitability. Organic growth is set at 3%-4% through 2028, rising above 5% by 2030, with major investments in M&A and technology to lead the market research sector.
Fiscal Year 2025
-
Revenue grew to EUR 2.525 billion in 2025, with organic growth of 0.6% and strong digital platform performance. Outlook targets 2%-3% organic growth in 2026, stable margins, and a EUR 100 million share buyback. Acquisitions and tech investments remain strategic priorities.
-
Q3 2025 saw improved organic growth, driven by private sector clients and digital services, while public affairs continued to weigh on results. Guidance for 2025 organic growth was revised to 0.7% due to ongoing political and budgetary challenges in key markets.
-
Organic growth reached 1.5% in H1, with profitability at 8.3% and free cash flow at €54 million. Acquisitions of BVA and INFAS expanded capabilities, while AI and digital platforms drove efficiency. Full-year growth and margin are expected to improve in H2.
-
Q1 2025 saw 2% revenue growth, with strong EMEA performance offset by declines in Asia-Pacific and public sector. AI adoption and the BVA acquisition are set to drive future growth, while margin guidance is maintained despite ongoing global uncertainty.
Fiscal Year 2024
-
Profitability and cash flow remained strong in 2024 despite modest revenue growth, with record gross margin and robust performance in EMEA and LATAM offsetting US headwinds. Investments in AI, digital platforms, and acquisitions continue, with 2025 organic growth expected to improve, especially in H2.
-
Year-to-date growth reached 3.3%, but Q3 saw a marked slowdown, especially in the U.S. EMEA, Latin America, and Ipsos Digital performed strongly, while public sector and healthcare segments declined. Operating margin is expected to remain robust at 13% for 2024.
-
Revenue grew 4.7% in H1 2024, with strong EMEA and digital performance offsetting U.S. weakness. Profitability and cash flow improved, but full-year growth guidance was revised to around 3% amid macro headwinds, especially in the U.S. and China.
-
The event outlined strong organic growth, robust financials, and a clear strategy focused on digitalization, AI, and targeted M&A. New GenAI products and platforms are driving productivity and innovation, while ESG and client-first initiatives support long-term differentiation and impact.